Clinical Trials Directory

Trials / Terminated

TerminatedNCT03222102

Ventral Hernia Prevention After Liver Transplantation

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate if the risk of developing ventral hernia after liver transplantation can be reduced through the prophylactic implantation of a synthetic, fully resorbable mesh "Phasix" in the course of liver transplantation. Patients will be randomized in a 1:1 ratio to receive either Phasix mesh or standard surgery without the use of Phasix. Ultra-sound examinations of the wound area will be performed 14 days, 3, 6 and 12 months after liver transplantation. Furthermore, presence of infections, seroma, pain and other problems in the wound area will be assessed.

Detailed description

Ventral hernia is a frequently occurring complication following liver transplantation, with a reported risk in the literature ranging from 5% to 25%. This study aims to evaluate if the risk of developing ventral hernia after liver transplantation can be reduced through the prophylactic implantation of a synthetic mesh "Phasix" in the course of liver transplantation. PHASIX™ Mesh is a fully resorbable mesh implant prepared from poly-4-hydroxybutyrate (P4HB). Absorption of the mesh material occurs within 12 to 18 months. Patients will be randomized in a 1:1 ratio to receive either Phasix mesh in the course of liver transplantation or standard surgery without the use of Phasix. Ultra-sound examinations of the wound area will be performed 14 days, 3, 6 and 12 months after liver transplantation. Furthermore, presence of infections, seroma, pain and other problems in the wound area will be assessed.

Conditions

Interventions

TypeNameDescription
DEVICEPhasix meshAfter the closure of the Abdomen, Phasix mesh will be placed and affixed on the exposed fascia.

Timeline

Start date
2017-11-30
Primary completion
2023-11-04
Completion
2023-11-04
First posted
2017-07-19
Last updated
2025-01-27

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT03222102. Inclusion in this directory is not an endorsement.

Ventral Hernia Prevention After Liver Transplantation (NCT03222102) · Clinical Trials Directory